Tag: NEO-implant

2 articles

Market Moves

Chinese BCI stocks rally as capital markets catch up with Neuracle and Science Corp

Nanjing Panda Electronics closed up nearly 13 percent in Hong Kong on 28 July as Chinese and Hong Kong-listed BCI stocks rallied, with capital markets repricing the field on the back of Neuracle's first commercial prescription and Science Corp's European CE mark.

Jul 28

Market Moves

Neuracle, maker of the world's first approved invasive BCI, files for a Shanghai STAR Market IPO with RMB 2.5B target raise

Neuracle, maker of the world's first approved invasive BCI, had a RMB 2.5B Shanghai STAR Market IPO prospectus accepted on 11 June 2026, opening a two-horse race with BrainCo for first publicly listed pure-play BCI.

Jun 22

Stay Ahead of the Curve

Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.

No spam. One-click unsubscribe. We respect your privacy.